Back
Shockwave Medical Quote, Financials, Valuation and Earnings
Sponsored
SWAV
Sponsored
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Buy
77
SWAV
Shockwave Medical
Last Price:
330.56
Seasonality Move:
19.33%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right hereShockwave Medical Price Quote
$330.56
-0.07 (-0.02%)
(Updated: May 8, 2024 at 6:50 PM ET)
Shockwave Medical Key Stats
Buy
77
Shockwave Medical (SWAV)
is a Buy
Day range:
$330.32 - $330.98
52-week range:
$157.00 - $331.58
Dividend yield:
0%
P/E ratio:
85.88
P/S ratio:
16.07
P/B ratio:
16.51%
Volume:
506.2K
Avg. volume:
1.7M
1-year change:
14.69%
Market cap:
$12.4B
Revenue:
$730.2M
EPS:
$4.28
How Much Does Shockwave Medical Make?
-
How Much Are Shockwave Medical's Sales Annually?
SWAV Revenues are $730.2M -
How Much Profit Does Shockwave Medical's Make A Year?
SWAV net income is $147.3M
Is Shockwave Medical Growing As A Company?
-
What Is Shockwave Medical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.36% -
What Is Shockwave Medical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.4%
Shockwave Medical Stock Price Performance
-
Did Shockwave Medical Stock Go Up Last Month?
Shockwave Medical share price went up by 1.31% last month -
Did SWAV's Share Price Rise Over The Last Year?
SWAV share price rose by 14.69% over the past 1 year
What Is Shockwave Medical 52-Week High & Low?
-
What Is Shockwave Medical’s 52-Week High Share Price?
Shockwave Medical has traded as high as $331.58 over the past 52 weeks -
What Is Shockwave Medical’s 52-Week Low Share Price?
Shockwave Medical has traded as low as $157.00 over the past 52 weeks
Shockwave Medical Price To Free Cash Flow
-
Is Shockwave Medical Stock Overvalued?
Shockwave Medical is trading at a price to free cash flow ratio of 76.21 -
Is Shockwave Medical Stock Undervalued?
Shockwave Medical EV to Free Cash Flow ratio is 72.93 -
What Is Shockwave Medical’s Price Earnings Growth Ratio?
SWAV PEG ratio is 0.00 -
Is Shockwave Medical Trading At A Premium To Earnings?
Shockwave Medical EV to EBIT ratio is 62.86
Is It Risky To Buy Shockwave Medical?
-
How Much Debt Does Shockwave Medical Have?
Total long term debt quarterly is $732.8M -
How Much Cash Does Shockwave Medical Have?
Cash and short term investments quarterly total is $1B -
What Is Shockwave Medical’s Book Value Per Share?
Book value per share is 20.04
Is Shockwave Medical Cash Flow Positive?
-
What Is SWAV Cash Flow From Operations?
Cash flow from operations (TTM) is $197.9M -
What Is Shockwave Medical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $522M -
What Is Shockwave Medical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$716.4M
Shockwave Medical Return On Invested Capital
-
Is Management Doing A Good Job?
SWAV return on invested capital is 14.77% -
What Is Shockwave Medical Return On Assets?
ROA measures how assets are converting to revenues and is 13.07% -
What Is SWAV Return On Equity?
ROE is a measure of profitability and is 25.47%
Shockwave Medical Earnings Date & Stock Price
-
What Is Shockwave Medical's Stock Price Today?
A single share of SWAV can be purchased today for 330.63 -
What Is Shockwave Medical’s Stock Symbol?
Shockwave Medical trades on the nasdaq under the ticker symbol: SWAV -
When Is Shockwave Medical’s Next Earnings Date?
The next quarterly earnings date for Shockwave Medical is scheduled on August 5, 2024 -
When Is SWAV's next ex-dividend date?
Shockwave Medical's next ex-dividend date is May 9, 2024 -
How To Buy Shockwave Medical Stock?
You can buy Shockwave Medical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Shockwave Medical Competitors
-
Who Are Shockwave Medical's Competitors?
Below is a list of companies who compete with Shockwave Medical or are related in some way:
Shockwave Medical Dividend Yield
Data Unavailable
Shockwave Medical Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 39.81% | 54.03% |
Revenue: | 35.85% | 5.37% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 11 |
Sell Recommendations: | 0 |
Price Target: | 310.43 |
Downside from Last Price: | -6.11% |